← Open Payments lookup

JACK HEIDENREICH: Open Payments

NPI 1316944374 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$888 in 53 payments from 17 companies in 2025. Trend: 2023 $331 · 2024 $710 · 2025 $888

Food & beverage: $888
CompanyPaymentsAmount
ABBVIE INC.22$345
Novo Nordisk Inc5$75
GlaxoSmithKline, LLC.4$67
Vanda Pharmaceuticals Inc.2$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$59
Bayer Healthcare Pharmaceuticals Inc.3$55
Astellas Pharma US Inc2$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
Lilly USA, LLC2$29
Exact Sciences Corporation1$20

Products named: QULIPTA, VRAYLAR, Ozempic, TRELEGY ELLIPTA, FANAPT, CAPLYTA, Kerendia, CREON.

Industry payments across LA — which companies pay providers there.